Insider Title Company Date Price Return Shares Value
Hoberman Kenneth Non-Executive Director Nuvectis Pharma, Inc. (NVCT) 2022-05-12 $17.40 -64.6% 6,000 $104,400
Return Profit / (loss) Cost
Total -64.6% $-67,440 $104,400